Cargando…
1593P COVID-19 vaccine acceptance among Tunisian cancer patients: A cross-sectional study
Autores principales: | Ouertani, E., Nesrine, M., Berrazega, Y., Rachdi, H., Bohli, M., Kochbati, L., Boussen, H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8454347/ http://dx.doi.org/10.1016/j.annonc.2021.08.1586 |
Ejemplares similares
-
Understanding COVID-19 vaccine hesitancy and resistance: another challenge in cancer patients
por: Mejri, Nesrine, et al.
Publicado: (2021) -
1635P Impact of the COVID-19 pandemic on cancer care in Tunisia: Oncologists' perception
por: Ben Abdallah, I., et al.
Publicado: (2021) -
Association between epidemiological and clinico-pathological features of breast cancer with prognosis, family history, Ki-67 proliferation index and survival in Tunisian breast cancer patients
por: Mighri, Najah, et al.
Publicado: (2022) -
1738P COVID-19: An additional burden on caregivers of cancer patients in Tunisia
por: Harbegue, K., et al.
Publicado: (2020) -
P1593: IMMUNE BIOMARKERS TO PREDICT SARS-COV-2 VACCINE EFFECTIVENESS IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES
por: Tamariz-Amador, L.-E., et al.
Publicado: (2022)